| 2025-03-19 | +0.89 % |
|
| 2025-03-18 | -1.05 % |
|
| 2025-03-17 | +0.73 % |
|
| 2025-03-12 | -1.79 % |
|
| 2025-03-07 | +1.53 % |
|
| 2025-03-06 | -1.91 % |
|
| 2025-03-05 | +0.09 % |
|
| 2025-03-04 | -1.88 % |
|
| 2025-02-14 | -0.9 % |
|
| 2025-02-13 | +1 % |
|
| 2025-02-12 | -0.72 % |
|
| 2025-02-11 | +0.1 % |
|
| 2025-02-07 | +0.66 % |
|
| 2025-01-27 | +3.52 % |
|
| 2025-01-24 | +1.47 % |
|
| 2025-01-23 | +4.62 % |
- Abbott Laboratories (ABT) stock rose 4.62% after the company reported fourth-quarter sales of $10.97 billion, which, although slightly below expectations, indicated strong organic growth in its underlying base business, particularly excluding COVID-19 testing-related sales.
- Abbott Laboratories (ABT) stock rose 4.62% following the news that Representative Thomas Kean purchased shares valued between $1,001 and $15,000, signaling investor confidence and potential positive sentiment towards the company.
- Abbott Laboratories (ABT) stock rose 4.62% likely due to a strategic investment and acquisition by Pluri Inc., a biotechnology company that is expanding into the cultivated cacao market, which is expected to strengthen its financial position and growth potential.
- Abbott Laboratories (ABT) stock rose 4.62% after receiving an "outperform" rating and a price target increase from multiple research analysts, indicating strong future performance expectations based on positive quarterly earnings and revenue growth.
- Abbott Laboratories (ABT) stock rose 4.62% likely due to positive investor sentiment around its business stability and growth prospects in the continuous glucose monitoring market, despite fears related to potential political changes in healthcare leadership.
|
| 2025-01-22 | +0.85 % |
|
| 2025-01-21 | +2.92 % |
|
| 2025-01-17 | -0.38 % |
|
| 2025-01-16 | +2.53 % |
|
| 2025-01-15 | -1.7 % |
|
| 2025-01-14 | -0.15 % |
|
| 2025-01-13 | +0.78 % |
|
| 2025-01-06 | -0.69 % |
|
| 2025-01-03 | +0.34 % |
|
| 2024-12-31 | +0.27 % |
|
| 2024-12-24 | +0.39 % |
|
| 2024-12-23 | +0.07 % |
|
| 2024-12-03 | -0.45 % |
|
| 2024-12-02 | -1.65 % |
|
| 2024-11-25 | +0.31 % |
|
| 2024-11-19 | -0.2 % |
|
| 2024-11-14 | -0.61 % |
|
| 2024-11-11 | +0.18 % |
|
| 2024-11-04 | -0.8 % |
|
| 2024-11-01 | +4.61 % |
|
| 2024-10-31 | -0.94 % |
|
| 2024-10-28 | -0.13 % |
|
| 2024-10-24 | -0.4 % |
|
| 2024-10-23 | +0.77 % |
|
| 2024-10-22 | -0.74 % |
|
| 2024-10-21 | -2.01 % |
|
| 2024-10-18 | +1.27 % |
|
| 2024-10-17 | +0.06 % |
|
| 2024-10-16 | +1.53 % |
|
| 2024-10-15 | -1.02 % |
|
| 2024-10-14 | +0.97 % |
|
| 2024-10-11 | +0.43 % |
|
| 2024-10-10 | -0.28 % |
|
| 2024-10-09 | +1.15 % |
|
| 2024-10-08 | +1.12 % |
|
| 2024-10-07 | +0.64 % |
|
| 2024-10-04 | +0.37 % |
|
| 2024-10-02 | +0.07 % |
|
| 2024-10-01 | -0.39 % |
|
| 2024-09-30 | +1.41 % |
|
| 2024-09-27 | -0.27 % |
|
